You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for POTASSIUM CHLORIDE 10MEQ


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 10MEQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-004-01 60 BAG in 1 CARTON (65219-004-01) / 50 mL in 1 BAG (65219-004-00) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-006-01 50 BAG in 1 CARTON (65219-006-01) / 100 mL in 1 BAG (65219-006-00) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-008-51 60 BAG in 1 CARTON (65219-008-51) / 50 mL in 1 BAG (65219-008-50) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-010-01 50 BAG in 1 CARTON (65219-010-01) / 100 mL in 1 BAG (65219-010-00) 2021-06-25
Fresenius Kabi Usa POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 211087 ANDA Fresenius Kabi USA, LLC 65219-012-01 50 BAG in 1 CARTON (65219-012-01) / 100 mL in 1 BAG (65219-012-00) 2021-06-25
Nexus POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 214727 ANDA Nexus Pharamaceuticals Inc. 14789-107-05 24 BAG in 1 BOX (14789-107-05) / 50 mL in 1 BAG (14789-107-08) 2021-02-28
Nexus POTASSIUM CHLORIDE 10MEQ potassium chloride INJECTABLE;INJECTION 214727 ANDA Nexus Pharamaceuticals Inc. 14789-107-10 24 BAG in 1 BOX (14789-107-10) / 100 mL in 1 BAG (14789-107-16) 2021-02-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Potassium Chloride 10mEq

Last updated: August 5, 2025

Introduction

Potassium chloride (KCl) is a vital electrolyte used in medical settings to correct potassium deficiencies and manage various medical conditions such as hypokalemia. The 10mEq formulation is a common dosage for intravenous (IV) and oral administration, widely supplied globally. Securing reliable suppliers for potassium chloride 10mEq ensures continuity of supply, quality, and compliance with regulatory standards—critical for pharmaceutical manufacturers, healthcare providers, and distributors.

This article examines the leading suppliers of potassium chloride 10mEq, analyzing their manufacturing capabilities, regulatory compliance, geographic distribution, and supply stability.

Global Supply Landscape of Potassium Chloride 10mEq

The global demand for potassium chloride stems from its essential role in clinical therapy. The market comprises several large-scale producers, specialty chemical manufacturers, and generic drug suppliers. The supply chain involves primary chemical manufacturers, bulk ingredient suppliers, and finished dosage form producers.

Major manufacturing hubs include North America, Europe, China, and India, which host numerous companies capable of producing pharmaceutical-grade potassium chloride compliant with international standards such as USP, EP, and JP.

Key Suppliers and Manufacturers

1. The Nippon Chemical Industrial Co., Ltd.

Overview: With a strong reputation in the pharmaceutical raw materials market, Nippon Chemical Industrial supplies high-purity potassium chloride, compliant with USP and EP standards. Their manufacturing facilities in Japan and China enable large-scale production with rigorous quality control.

Capabilities:

  • Produces pharmaceutical-grade potassium chloride for both oral and injectable formulations.
  • Adheres strictly to cGMP guidelines, ensuring regulatory compliance globally.
  • Offers custom packaging and bulk supply options.

Supply Stability: Known for stable supply chains and robust quality management, Nippon Chemical supplies major pharmaceutical companies worldwide.

2. Fosfa A/S

Overview: A Danish company with extensive chemical manufacturing expertise, Fosfa produces potassium chloride used in clinical and industrial applications.

Capabilities:

  • International distribution network supporting pharmaceutical-grade KCl.
  • Supplies both bulk and packaged potassium chloride for pharmaceutical and nutritional uses, including 10mEq formulations.

Certifications and Compliance:

  • Certified under ISO 9001, ISO 13485 for medical-grade products.
  • Compliant with multiple pharmacopeias (USP, EP).

3. Kunshan Yake Chemical Co., Ltd.

Overview:
Based in China, Yake Chemical specializes in active pharmaceutical ingredients (APIs) and excipients, including potassium chloride.

Capabilities:

  • Large-scale manufacturing facilities approved by CFDA, with GMP certification.
  • Supplies high-purity potassium chloride suitable for injections and oral forms, including 10mEq packs.

Supply Stability:
Supported by China's extensive manufacturing infrastructure, ensuring cost-effective, reliable supply chains.

4. Wuhan Huishen Pharmaceutical Co., Ltd.

Overview:
A Chinese pharmaceutical company known for producing electrolytes and essential salts, including potassium chloride.

Capabilities:

  • Offers pharmaceutical-grade potassium chloride in various formulations, including injectable solutions at 10mEq.
  • Meets international pharmacopeial standards, with export licenses to multiple regions.

5. Baxter International Inc.

Overview:
A global healthcare leader, Baxter supplies ready-to-use electrolyte solutions, including potassium chloride injections.

Capabilities:

  • Extensive portfolio of sterile electrolyte products.
  • Strict adherence to regulatory standards like FDA, EMA, and JP.
  • Ensures high purity, safety, and compatibility with clinical needs.

Supply Chain:
Global manufacturing footprint ensures continuous supply, critical for hospitals and healthcare systems.

6. Pfizer Inc.

Overview:
Pfizer manufactures and supplies pharmaceutical-grade electrolytes, including potassium chloride for IV and oral dosage.

Capabilities:

  • Extensive distribution channels.
  • Utilizes state-of-the-art manufacturing facilities in North America and Europe.
  • Provides potassium chloride 10mEq in pre-filled syringes, bags, and oral forms.

7. Praxair (Linde plc)

Overview:
Through its pharmaceutical-grade gas and reagent divisions, Praxair supplies high-purity potassium chloride for pharmaceutical manufacturing.

Capabilities:

  • Custom formulations for various applications.
  • Emphasizes purity and compliance with international standards.

Regulatory and Quality Considerations

Suppliers must comply with strict regulatory standards such as USP, EP, JP, and FDA current Good Manufacturing Practices (cGMP). Validation of raw materials, rigorous quality control testing, traceability, and certification are prerequisites in sourcing pharmaceutical-grade potassium chloride. Many major suppliers hold certifications from international authorities, ensuring their products meet clinical safety and efficacy requirements.

Regional Distribution and Market Dynamics

The supply of potassium chloride is influenced by geopolitical stability, manufacturing capacity, and regulatory environments. North American and European providers predominantly cater to advanced markets, ensuring high compliance standards. Conversely, Chinese and Indian suppliers provide cost-effective options, often supplying bulk raw materials for further formulation.

The industry faces periodic supply challenges due to raw material shortages, transportation disruptions, or regulatory changes, highlighting the importance of establishing relationships with multiple reputable suppliers.

Supply Chain Considerations

  • Quality Assurance: Always verify suppliers' certifications and adherence to pharmacopeial standards.
  • Regulatory Status: Ensure the product’s registration status in target markets.
  • Lead Time and Capacity: Factor in manufacturing lead times, minimum order quantities, and scalability.
  • Cost vs. Reliability: Balance cost efficiencies with supplier reliability and regulatory compliance.

Conclusion

The landscape of potassium chloride 10mEq suppliers is characterized by a mix of global chemical manufacturers, pharmaceutical companies, and regional producers. Top-tier suppliers—such as Nippon Chemical Industrial, Fosfa A/S, Baxter, and Pfizer—offer high-quality, compliant products with stable supply chains suited for pharmaceutical use. Chinese manufacturers like Kunshan Yake and Wuhan Huishen provide cost-effective options, underlining the importance of due diligence regarding regulatory compliance.

Securing reliable, compliant suppliers is critical for maintaining uninterrupted delivery, meeting regulatory requirements, and ensuring patient safety.


Key Takeaways

  • Global Market Leaders: Major suppliers like Baxter, Pfizer, Nippon Chemical, and Fosfa dominate high-quality potassium chloride supply, offering consistency and regulatory compliance.
  • Compliance is Critical: Always verify that suppliers meet pharmacopeial standards (USP, EP, JP) and hold necessary certifications.
  • Regional Considerations: Balance supply cost, reliability, and regulatory approval—especially when sourcing from China or India for cost savings.
  • Supply Chain Stability: Diversify suppliers to mitigate risks of raw material shortages or logistical disruptions.
  • Regulatory Vigilance: Ensure products are registered and approved in your target markets before procurement.

FAQs

1. What are the key regulatory standards for pharmaceutical potassium chloride?
Pharmaceutical potassium chloride must comply with standards like USP (United States Pharmacopeia), EP (European Pharmacopoeia), and JP (Japanese Pharmacopoeia). Regulatory agencies such as the FDA, EMA, and PMDA enforce these standards, ensuring safety, efficacy, and quality.

2. How do I verify the quality of potassium chloride suppliers?
Request certifications (cGMP, ISO), and review batch testing reports, purity analyses, and compliance documentation. Insist on suppliers with validated manufacturing processes and prior regulatory approvals.

3. What are the main factors affecting the supply continuity of potassium chloride?
Factors include raw material availability, geopolitical stability, manufacturing capacity, transportation logistics, and regulatory compliance. Supplier diversification reduces risk.

4. Can potassium chloride from regional suppliers meet global standards?
Yes, many regional suppliers in China and India produce pharmaceutical-grade potassium chloride that meets international standards but require thorough verification of certifications and quality assurance measures.

5. Is there a difference between buying potassium chloride for industrial versus pharmaceutical purposes?
Yes. Pharmaceutical-grade potassium chloride must comply with stricter quality and purity standards, undergo rigorous testing, and be certified according to pharmacopeial specifications, unlike industrial-grade products.


Sources

[1] U.S. Pharmacopeia Convention, “USP Monographs for Potassium Chloride,” 2023.
[2] European Pharmacopoeia, “Potassium Chloride Monograph,” 2022.
[3] International Pharmaceutical Regulators Forum, “Guidelines on Pharmaceutical Raw Material Approval,” 2021.
[4] Company websites: Nippon Chemical Industrial, Fosfa A/S, Baxter, Pfizer.
[5] Market analysis reports: Global Pharmaceutical Electrolytes Market, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.